Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 5
2019 4
2020 2
2021 2
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study.
Mahajan UM, Erber J, Shamsrizi P, Voit F, Vielhauer J, Johlke AL, Benesch C, Khaled NB, Reinecke F, Rudi WS, Klein M, Jakob C, Oswald M, König R, Schulz C, Mayerle J, Stubbe HC. Mahajan UM, et al. Infection. 2023 Dec;51(6):1669-1678. doi: 10.1007/s15010-023-02041-8. Epub 2023 May 11. Infection. 2023. PMID: 37166617 Free PMC article.
(1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Bloos F, Held J, Kluge S, Simon P, Kogelmann K, de Heer G, Kuhn SO, Jarczak D, Motsch J, Hempel G, Weiler N, Weyland A, Drüner M, Gründling M, Meybohm P, Richter D, Jaschinski U, Moerer O, Günther U, Schädler D, Weiss R, Putensen C, Castellanos I, Kurzai O, Schlattmann P, Cornely OA, Bauer M, Thomas-Rüddel D; SepNet Study Group. Bloos F, et al. Intensive Care Med. 2022 Jul;48(7):865-875. doi: 10.1007/s00134-022-06733-x. Epub 2022 Jun 16. Intensive Care Med. 2022. PMID: 35708758 Free PMC article. Clinical Trial.
Another trial for the TARGET trial. Author's reply.
Hagel S, Pletz MW, Lehmann T. Hagel S, et al. Intensive Care Med. 2022 Jun;48(6):776-777. doi: 10.1007/s00134-022-06670-9. Epub 2022 Mar 23. Intensive Care Med. 2022. PMID: 35320369 Free PMC article. No abstract available.
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand M, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Intensive Care Med. 2022 Mar;48(3):311-321. doi: 10.1007/s00134-021-06609-6. Epub 2022 Feb 1. Intensive Care Med. 2022. PMID: 35106617 Free PMC article. Clinical Trial.
The epidemiology of bloodstream infections and antimicrobial susceptibility patterns in Thuringia, Germany: a five-year prospective, state-wide surveillance study (AlertsNet).
Schöneweck F, Schmitz RPH, Rißner F, Scherag A, Löffler B, Pletz MW, Weis S, Brunkhorst FM, Hagel S. Schöneweck F, et al. Antimicrob Resist Infect Control. 2021 Sep 8;10(1):132. doi: 10.1186/s13756-021-00997-6. Antimicrob Resist Infect Control. 2021. PMID: 34493334 Free PMC article.
18 results